Company page

Lexaria Bioscience Corp.

Lexaria Bioscience Corp. (Ticker: LEXX) is a public company based in the United States, with a market capitalization of approximately $13.86 million. The company focuses on developing innovative drug delivery technologies, particularly in the field of cannabinoid delivery. Lexaria aims to enhance the bioavailability and effectiveness of various compounds through its proprietary methods.